| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000017354 |
| Receipt No. | R000019163 |
| Scientific Title | Neurological deficit associated with osteoporotic vertebral fracture: evaluation of clinical features from a prospective multicenter study |
| Date of disclosure of the study information | 2015/05/01 |
| Last modified on | 2021/05/06 (Ver. 6) |
| Basic information | ||
| Public title | Neurological deficit associated with osteoporotic vertebral fracture: evaluation of clinical features from a prospective multicenter study | |
| Acronym | Neurological deficit associated with osteoporotic vertebral fracture: a prospective multicenter study | |
| Scientific Title | Neurological deficit associated with osteoporotic vertebral fracture: evaluation of clinical features from a prospective multicenter study | |
| Scientific Title:Acronym | Neurological deficit associated with osteoporotic vertebral fracture: a prospective multicenter study | |
| Region |
|
|
| Condition | ||
| Condition | Osteoporotic vertebral fracture | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To clarify the clinical characteristics in epidemiology, symptoms and radiological findings in patients with osteoporotic vertebral fracture associated with neurological deficit |
| Basic objectives2 | Others |
| Basic objectives -Others | Analysis of clinical features of osteoporotic vertebral fracture causing neurological deficit |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Patients' background
Symptoms and neurological findings Imaging findings |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | Investigation of patients' background, symptoms, neurological deficits and imaging findings on plain x-ray, CT and MRI of the spine.
The investigation will be performed in patients having osteoporotic vertebral fracture associated with neurological deficit. |
|
| Interventions/Control_2 | Investigation of patients' background, symptoms, neurological deficits and imaging findings on plain x-ray, CT and MRI of the spine.
The investigation will be performed in patients having osteoporotic vertebral fracture without neurological deficit. |
|
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Inclusion criteria of patients with neurological deficit:
1. having osteoporotic vertebral fracture 2. having neurological symptom due to the fracture 3. having neurological sign 4. the neurological disturbance caused at the fracture site or at the upper or lower adjacent intervertebral level 5. regardless of presence of degenerative change in the lumbar spine such as spondylolisthesis and spinal canal narrowing 6. regardless of the treatment method Inclusion criteria of patients without neurological deficit is to meet the criteria 1, 5 and 6 but not 2, 3, or 4 in above. |
|||
| Key exclusion criteria | i) Neurological disturbance caused from other factor than ii) the fracture
iii) Fracture united and healed completely iv) Secondary osteoporosis v) Incapability of the imaging examination vi) Without the patient's consent |
|||
| Target sample size | 200 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Tohoku University Hospital | ||||||
| Division name | Department of Orthopaedic Surgery | ||||||
| Zip code | 9808574 | ||||||
| Address | 1-1 Seiryo-machi Aoba-ku Sendai | ||||||
| TEL | 022-717-7245 | ||||||
| kanno-h@isis.ocn.ne.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Tohoku University Hospital | ||||||
| Division name | Department of Orthopaedic Surgery | ||||||
| Zip code | 9808574 | ||||||
| Address | 1-1 Seiryo-machi Aoba-ku Sendai | ||||||
| TEL | 022-717-7245 | ||||||
| Homepage URL | |||||||
| kanno-h@isis.ocn.ne.jp | |||||||
| Sponsor | |
| Institute | Department of Orthopaedic Surgery, Tohoku University school of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Department of Orthopaedic Surgery, Tohoku University school of Medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Independent Ethics Committee of Tohok University School of Medicine |
| Address | 1-1 Seiryo-machi Aoba-ku Sendai |
| Tel | 022-717-8007 |
| med-kenkyo@bureau.tohoku.ac.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000019163 |